上海盟科药业股份有限公司2025年第三次临时股东大会决议公告

Core Points - The company held a shareholders' meeting on November 7, 2025, with all resolutions passed without any objections [4][6] - The meeting was chaired by the chairman Zhengyu Yuan and complied with the relevant laws and company regulations [2][7] - All directors and supervisors were present at the meeting, ensuring full participation [3] Proposal Review - The proposal to abolish the supervisory board and amend the Articles of Association was approved [4] - The proposal to revise certain corporate governance systems was also approved [4] - The proposal to appoint the auditing firm for the fiscal year 2025 was passed [4] - A proposal regarding changes to certain fundraising investment projects was approved [6] - The proposal to purchase liability insurance for directors and senior executives was also approved [6] Voting and Legal Compliance - The voting process was conducted through a combination of on-site and online methods, adhering to the Company Law and the company's Articles of Association [2] - The legal firm Shanghai Fangda Law Firm witnessed the meeting, confirming that all procedures were in compliance with applicable laws and regulations [7]